Dibekacin

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Dibekacin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1979. DrugCentral lists 1 molecular target, including mphB.

• Molecular targets: mphB (1 listed in DrugCentral).
• ATC code: J01GB09 (Other aminoglycosides).
• Molecular formula: C18H37N5O8; molecular weight 451.52 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)	mphB	unknown	Km 5.92

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1979-01-01	YEAR INTRODUCED	—	—

ATC classification

ATC code	Therapeutic hierarchy
J01GB09	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › AMINOGLYCOSIDE ANTIBACTERIALS › Other aminoglycosides
S01AA29	SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIINFECTIVES › Antibiotics

Chemical structure

• Molecular formula: C₁₈H₃₇N₅O₈
• Molecular weight: 451.52 g/mol
• CAS number: 34493-98-6
• InChIKey: JJCQSGDBDPYCEO-XVZSLQNASA-N
• PubChem CID: 470999

NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Dibekacin work?

Its molecular targets in DrugCentral include mphB.

When was Dibekacin first approved?

Dibekacin was first approved by the YEAR INTRODUCED in 1979.

What is the chemical formula of Dibekacin?

Dibekacin has the molecular formula C18H37N5O8 and a molecular weight of 451.52 g/mol.

Sources

• DrugCentral drug card 855 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL560976 — compound record and bioactivity
• PubChem CID 470999 — chemical identifiers
• DrugBank DB13270 — drug record
• FDA UNII 45ZFO9E525 — substance identity

How this page is built: methodology · editorial policy & corrections.